Free Consultation with Dr. R. Ranga Rao

consult dr r ranga rao best oncologist paras hospital delhi

Profile Overview

Dr. (Col) R. Ranga Rao is an eminent Oncologist who served in the medical fraternity and armed forces for approximately 30 years. Currently Dr. Ranga Rao is Medical Oncologist at Paras Hospital Delhi, NCR. Dr Ranga Rao is specialized in the Bone Cancer, Tumor Specialist, Lymphoma Cancer Specialist, and Best Oncology Centre Delhi. His skills lie in Chemotherapy, Hormonal Therapy, Targeted Therapy, Supportive Care and Palliative Care. After completion of his MBBS and internship, Dr. Rao started his professional career in the year 1977 when he was commissioned as a permanent officer in the army. After his post-graduation (MD) in 1984 and serving as an Internal Medicine Specialist for seven years, Dr. Ranga Rao then completed his DM in Medical Oncology in 1993. He was then attached to the oncology centers as Medical Oncologist at the armed forces at Kolkata, Pune, and Mumbai for the next nine years after which Best medical oncologist in Delhi was promoted to Colonel. Fill up the free consultation form to consult the best medical oncologist in Delhi via Email Address.

Dr. Rangaraju Best Oncologist in India has been associated with several established hospitals and institutes. He was also designated as Professor and Senior Advisor in Medical Oncology. Best Cancer Specialist & Oncologist in Delhi oversaw the management of all malignancies (adult and pediatric) and was instrumental in establishing a 16-bed day care center, a LAN based OPD Centre and forming the Armed forces Oncology Group (AFOG) with officially approved chemotherapy protocols. Top oncologist in Delhi also conducted research here involving weekly chemotherapy in head, esophageal, neck, and cervical malignancies. After opting for voluntary retirement from the AMC, Best medical oncologist in Delhi was associated with the Rajiv Gandhi Cancer Institute and established the Artemis cancer center. Best cancer doctor in Delhi conducted several camps for cancer patients and cancer awareness programmers for primary care physicians and the general public. Get in touch with us to book your appointment with the best medical oncologist in Delhi, India.

Dr. Ranga Rao Rangaraju is an award winner of distinction and having conducted several clinical trials over the years, he has been extensively involved in research. He has had considerable international exposure, having attended courses and workshops, and visited cancer hospitals of repute worldwide. He is also a prolific writer of papers and research-based articles, which have been published in peer-reviewed journals and other prominent publications. He has also delivered hundreds of lectures and presentations at conferences and professional meets. In addition to this, he also has vast teaching experience and has organized many CME sessions across the country. Book Appointment with Oncologist at Paras Hospital Delhi NCR via Dr Ranga Rao Contact Number given on the website.

Education

MBBS from Jawaharlal Nehru Medical College, Ajmer, 1977
MD from Internal Medicine - Armed Forces Medical College (AFMC), Pune, 1984
DM (Oncology) from Cancer Institute (WIA), Chennai, 1993

Specialities

Medical Oncologist
Head & Neck Cancer
Uro Gynae Oncology
Lung Cancer

Doctor Experience

Currently work Chairman, Paras Cancer Centers, Paras Hospital, Sushant Lok Phase 1, Gurgaon, 122002
Senior Director, Oncology Services, Max Institute of cancer Care, Max Super-Speciality Hospital, Shalimar Bagh
Sr. Consultant & Director in Medical Oncology Department at BLK Super Speciality Hospital, 2011-2014
Professor & Sr. Consultant Medical Oncology at Rajiv Gandhi Cancer Institute & Research Centre, 2006-2011
Senior Adviser Oncology at Army Hospital (Referal and research), New Delhi, 2002-2006
Specialist in Medicine and Oncology at Armed Forces Medical Services, 1977-2002

Memberships

Member, American Society of Clinical Oncology (ASCO)
Member, European Society of Medical Oncology (ESMO)
Member, Indian Society of Medical and Paediatric Oncology (ISMPO)
Member, Indian Society of Oncology (ISO)
Member, Association of Physicians of India (API)
Member, Indian Cooperative Oncology Network (ICON)
Chairman, Medical Audit Committee at Rajiv Gandhi Cancer Institute during his tenure at the institute.
Member, Management Committee at Rajiv Gandhi Cancer Institute during his tenure at the institute
Chairman, IT Project (Clinical) at Rajiv Gandhi Cancer Institute during his tenure at the institute

Awards and Recognitions

Sheetal Sahai Oration 2019 at Cancer institute and research centre, Gwalior
Sushruta Award 2018 Max Health Care for best innovative department.
2nd Best Post Award, March 2012
Vishisht Seva Medal, 2006
Air Marshal Ajit Nath Guru Shanti Devi Award, 1997
Best Paper Award MJAFI, 1996
Best Original Article Award, 1995
Lt Gen R S Hoon Award, 1995
Lt. Gen. RS Hoon Award, 1994
Col K K Gupta Gold Medal, 1984

Publications

Vineet Govinda Gupta, Ranga Rao Rangaraju, Waseem Abbas, Peush Bajpai, and Ruchika Khetrapal. Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68.
Waseem Abbas, Ranga Rao Rangaraju, Vineet Govinda Gupta, Swati Popli. Immunotherapy-induced interstitial lung disease: Cases report. South Asian Journal of Cancer 8(2):79 • April 2019
Rangarao R, Smruti BK, Singh K, Gupta A, Batra S, Choudhary RK, et al. Practical consensus recommendations on management of triplenegative metastatic breast cancer. South Asian J Cancer 2018;7:127-31.
Vineet Govinda Gupta, R Ranga Rao, Rajat Saha, Peush Bajpai. Pazopanib Monotherapy is active in relapsed and refractory metastatic gastroesopheal adenocarcinoma and can produce durable response. Journal of Gastrointestinal Cancer July 2018
R Ranga Rao, Cancer awareness amongst nurses in a tertiary care hospital in north Delhi, India. By IJMPO, August 2017.
Sheh Rawat, Praveen Ahlawat, Anjali Kakria, Gaurav Kumar, Ranga Rao Rangaraju, Abhishek Puri, Manoj Pal, Deepika Chauhan, Bharti Devnani, Pranav Chadha. Comparison between weekly cisplatin-enhanced radiotherapy and cetuximab-enhanced radiotherapy in locally advanced head and neck cancer: first retrospective study in Asian population. Asia pacific journal of clinical Oncology. Vol 13.3, June 2017 195-203.
S Jain, S Singh, MM Sankar, R Saha, RR Rangaraju, TD Chugh. Catheter-related bacteremia due to M. chelonae in an immunocompromised Patient: An emerging nosocomial pathogen. Indian journal of medical microbiology 30(4):489-91, 2012
Poster Presentation: A case of CaBuccal Mucosa, Recurrent SCC on Erbitux + chemotherapy till progression, head & neck cancer Case Study Poster. Dr. (Col.) R Ranga Rao. Merck Serono Oncology Summit. Hong Kong, 2012.
Targeted therapies for non small cell lung cancer. Lung Cancer. Ranga Rao Raju. 2012; 49 (1):1-5.
Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic headand neck cancers: A retrospective analysis. Rangaraju RR, Sharma JB, Dewan AK, Anand AK, ShehRawat, Jena A, Chaturvedi AK. Indian Journal of Cancer. Jan-Mar 2012; 49(1):1-5.
Ranga Rao Rangaraju, Sarkar U. Medicine Update. 2009; Volume 19 Part II; 955-966.
Unusual responses of refractory solid tumours to thalidomide. Ranga Rao Rangaraju, Konnpal Anil, Ajit Venniyoor, Harinder Singh, Subhash Ranjan and B Kapur. Asia Pacific Journal of Clinical Oncology. 2008; Vol 4; issue 2: 113-117.
Colony stimulating factors: current recommendations. Rao Ranga R, Venniyoor Ajit Kumar Rajat. Postgraduate Medicine. 2007; pp. 124-136.
Paraneoplastic hypercalcaemia in association with metabolic complications, in advanced carcinoma of oral cavity. Pande BS, Anil K, Khatri S, Rao Ranga R. IJMPO; 2007; 28(2): 44-46.
Migration of entire peripherally-inserted central catheter to pulmonary arteries: an unusual complication. Pandey BS, Rustogi P, Anil K, Khatri S, Rao Ranga R. IJMPO. 2007; 28(1): 33-36.
Multiple myeloma presenting with hepatic involvement: A rare presentation. Dhiman A, Bansal RL, Sekhon JS, Rao Ranga R, Sekhon A, Neeraj. IJMPO. 2007.
Survival benefit and efficacy of gefitinib in recurrent/metastatic head and neck cancers. Rao Ranga R, Anil K, Bansal RL, Dhiman A, Khatri S, Rawat S, Dewan K A. IJMPO. 2007.
Triplet combination of gemcitabine, oxaliplatin and continuous infusion 5 FU (FOG) in the treatment of locally advanced or metastatic carcinoma of gall bladder. Venniyoor AJ, Singh HP, Rao Ranga R. ESMO. 2006. [Abstract]
Treatment of lung cancer in elderly. Parikh P, Rao Ranga R. Lung Cancer. 2006; Vol 1, 203-211.
Paediatric acute myeloblasticleukemia: experience with an intensive chemotherapy protocol - a pilot study. H P Singh, Rao Ranga R, Nair Velu, Venniyoor AJ. Ind J of ISMPO. 2005; 26No.3, 10-14.
Prognostic factors in ALL. Rao Ranga R. Proceedings of ISMPO. 2004.
Adjuvant therapy of early ovarian cancer. Ranga Rao R; Venniyoor AJ; Singh HP. Ind J of Med Paed Oncol. 2004; Apr; 25(1): 18-20.
Targeted therapy in haematological malignancies. Rao Ranga R. (Proceedings of APICON 2004). Medicine Update. 2004; Vol 14, 343-353.
Comprehensive cancer care. Rao Ranga R. Oncology Update, CME Book. 2003; 70-75.
Oncological emergencies. Rao Ranga R, Venniyoor AJ. Armed Forces Medical Manual. 2003.
Hodgkin's disease. Rao Ranga R. Medicine Update, CME Book. Nov 2002.
Chemo radiotherapy in head and neck cancers. Rao Ranga R. Oncology Update Proceedings. Nov 2000. AH RR New Delhi.
Moderate doses of alpha interferon 2b therapy with concurrent hydroxyurea in patients of CML benefits early, late chronic phase and accelerated phase. 5-year follow up. Rao Ranga R, Sarma YS, Lakhtakia R, Nandi S. Blood. Dec 2000. [Abstract]
Poster Presentation: Weekly chemotherapy in head and neck malignancies. Rao Ranga R. Asia Pacific Cancer Conference. Chennai, 1999.
Weekly chemotherapy in head and neck malignancies. Rao Ranga R. ASIA Pacific Cancer Conference. Chennai, 1999. [Abstract]
Bone marrow and peripheral blood stem cell transplantation in the treatment of malignancies. Rao Ranga R. Proceedings of CME of AFMRC. Feb 1998.
Improved outcome with multimodal management of advanced esthesioneuroblastoma. Rao Ranga R, Sarma YS, Mukherjee S, Mukhopadhyay SM. MJAFI. 1998; 54,79-81.
Impact of prophylactic use of colony stimulating factors on the pattern of neutropenia and infections in moderately intensive chemotherapy. Rao Ranga R, Sarma YS, Malik R. MJAFI. 1997; 53, 183-188.
Haemopoietic growth factors in malignancies. Kumar R, Rao Ranga R. JAPI. Nov 1995.
Use of long term venous access with Hickmann catheter in patients of acute leukaemia. Kumar R, Kumar Harsh, Rao Ranga R. MJAFI. 1995; 51,231-236.
Introduction to interferons. Rao Ranga R. JAPI (suppl). Nov 1995.
Immunophenotyping of acute leukaemia. Critical analysis of 35 patients. Kumar H, Kumar R, Sivadas P, Panayach JS, Rao RR, Bhardwaj. MJAFI. 1995; 51(3): 165-9.
Curable cancers. Rao Ranga R. Proceedings of National Medicine Update. AFMC. 1995.
Haemopoietic growth factors in malignancies. Rao Ranga R. JAPI. Nov 1995.
Tumour associated blood eosinophilia [correspondence]. Kumar H, Sivadas P, Rao RR. MJAFI. 1995 Jan; 51(1): 75-6.
An experience with patients of chronic myeloid leukaemia in a service hospital. Rao Ranga R, Sarma YS, Laktakia R. APICON. Chennai, 1995.
Pachydermoperiostosis (a report of four cases). Rao Ranga R, Tutakne AK, Dham SK, Ahuja IM. MJAFI. 1986; 42. 4,314-8.
Integrated approach to the management of patients with advanced germ cell tumors of the testis. R Ravi, R Ranga Rao, V Shanta. JSO. ISSN: 0022-4790, 1994; 55 (1): 47.
Block: ECG Diagnosis. Rao Ranga R, Kalra SP. Bilevel AV. J App Med. Nov 1989.
X Ray Diagnosis: Hypertrophic Osteoarthropathy. Rao Ranga R, Kalra S. J Applied Medicine (accepted).
Dr. Ranga Rao Rangaraju has read and presented research papers and delivered lectures at over 110 conferences, professional meets and CMEs at various hospitals, institutes and events across the country and abroad. He has also made presentations for the lay public at community forums, schools, etc.
Paediatric Acute Myeloblastic Leukemia: Experience with an Intensive Chemotherapy Protocol- A Pilot Study.
Paraneoplastic Hypercalcaemia in Advanced Carcinoma of Oral Cavity.
Survival Benefit and Efficacy of Gefitinib in Recurrent/ Metastatic Head and Neck Cancer.
Phase II Trial of Neoadjuvant Chemotherapy in Cervical Cancer in Indian Women.
Adjuvant Therapy of Early Ovarian Cancer.
Medical Management of Malignancies.

Dr. R. Ranga Rao – Best Oncologist in India
For Fast Track Query Reply Email - dr.rrangarao@indiacancersurgerysite.com
For Instant Appointment - +91-9371770341
Get Urgent Medical Advice, Send Reports -